Facilitating Research

SPOR is dedicated to creating environments that are conducive to patient-oriented research all across Canada. Because research funding by itself is only one piece of the puzzle, SPOR also establishes provincial and territorial hubs so that the research reaches patients, caregivers, families, policy makers, and health care providers.

SPOR facilitates patient-oriented research through:

  • SPOR SUPPORT Units: These provincial/territorial-based organizations provide access to data and training to researchers, clinicians, patients, and policy makers interested in conducting patient-oriented research.
  • SPOR Evidence Alliance: This alliance, led by Dr. Andrea Tricco and including more than 175 members across Canada, is creating a coordinating centre to which knowledge-users can submit health research questions, which will then be matched to experts who will conduct systematic reviews and knowledge synthesis research to address the topic. The goal of the alliance is to respond to at least 100 questions over its five-year term of funding, conduct systematic reviews, develop guidelines, provide mentorship and training opportunities, and engage in knowledge translation to ensure health care providers have the evidence to provide patients with the right care at the right time.  
  • The Canadian Clinical Trials Coordinating Centre (CCTCC): The CCTCC is a body that brings stakeholders together to strengthen the Canadian clinical trials environment and promote Canada as a leading destination for clinical trials globally through policy development, advocacy, standardization, and evaluation. Some achievements to date include:
    • Canadian Clinical Trials Asset Map
      The Canadian Clinical Trials Asset Map (CCTAM) is a unique, robust, searchable web-based database designed to showcase Canada’s clinical research strengths to all stakeholders, including clinical trial sponsors and position Canada as an attractive global destination for the conduct of clinical trials.
    • Model Clinical Trial Template Agreement
      The model Clinical Trial Agreement (mCTA) provides a standard model contract for use by clinical trial sites and sponsors in negotiating phase II and phase III clinical trial agreements.
    • Streamlining Research Ethics Review for Multi-Centre Trials
      Under SPOR, CIHR established the External Advisory Committee on Streamlining Health Research Ethics Review (SHRER) to address Recommendation 4 of the Clinical Trials Summit Action Plan by gathering information on streamlining initiatives in Canada and making recommendations for improving the process of ethics review for multi-centre patient-oriented research. SHRER Committee’s final recommendations [ PDF (2.48 MB) - external link ]

Did you know ?

There are SUPPORT Units in 13 provinces and territories

The “SUPPORT” stands for “Support for People and Patient-Oriented Research and Trials.”

Date modified: